127 related articles for article (PubMed ID: 10026267)
21. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
22. N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.
Lee SM; Booe JM; Gingell JJ; Sjoelund V; Hay DL; Pioszak AA
Biochemistry; 2017 Jul; 56(26):3380-3393. PubMed ID: 28614667
[TBL] [Abstract][Full Text] [Related]
23. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
24. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues.
Shimizu N; Petroni BD; Khatri A; Gardella TJ
Biochemistry; 2003 Mar; 42(8):2282-90. PubMed ID: 12600195
[TBL] [Abstract][Full Text] [Related]
25. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
26. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
27. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
28. Human calcitonin receptor is directly targeted to and retained in the basolateral surface of MDCK cells.
Nussenzveig DR; Matos MD; Thaw CN
Am J Physiol; 1998 Nov; 275(5):C1264-76. PubMed ID: 9814975
[TBL] [Abstract][Full Text] [Related]
29. A protein engineering approach differentiates the functional importance of carbohydrate moieties of interleukin-5 receptor α.
Ishino T; Economou NJ; McFadden K; Zaks-Zilberman M; Jost M; Baxter S; Contarino MR; Harrington AE; Loll PJ; Pasut G; Lievens S; Tavernier J; Chaiken I
Biochemistry; 2011 Sep; 50(35):7546-56. PubMed ID: 21770429
[TBL] [Abstract][Full Text] [Related]
30. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.
Houssami S; Findlay DM; Brady CL; Myers DE; Martin TJ; Sexton PM
Endocrinology; 1994 Jul; 135(1):183-90. PubMed ID: 8013352
[TBL] [Abstract][Full Text] [Related]
31. Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction.
Zhang Z; Austin SC; Smyth EM
Mol Pharmacol; 2001 Sep; 60(3):480-7. PubMed ID: 11502878
[TBL] [Abstract][Full Text] [Related]
32. Role of Asn-16 and Ser-19 in anthopleurin B binding. Implications for the electrostatic nature of Na(V) site 3.
Seibert AL; Liu J; Hanck DA; Blumenthal KM
Biochemistry; 2004 Jun; 43(22):7082-9. PubMed ID: 15170345
[TBL] [Abstract][Full Text] [Related]
33. Identification and importance of N-glycosylation of the human 5-hydroxytryptamine3A receptor subunit.
Monk SA; Williams JM; Hope AG; Barnes NM
Biochem Pharmacol; 2004 Nov; 68(9):1787-96. PubMed ID: 15450944
[TBL] [Abstract][Full Text] [Related]
34. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.
Zhong M; Navratil AM; Clay C; Sanborn BM
Biochemistry; 2004 Mar; 43(12):3490-8. PubMed ID: 15035619
[TBL] [Abstract][Full Text] [Related]
35. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.
Gorn AH; Rudolph SM; Flannery MR; Morton CC; Weremowicz S; Wang TZ; Krane SM; Goldring SR
J Clin Invest; 1995 Jun; 95(6):2680-91. PubMed ID: 7769107
[TBL] [Abstract][Full Text] [Related]
36. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
Hilton JM; Dowton M; Houssami S; Sexton PM
J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
[TBL] [Abstract][Full Text] [Related]
37. Role of N-linked glycosylation on the function and expression of the human secretin receptor.
Pang RT; Ng SS; Cheng CH; Holtmann MH; Miller LJ; Chow BK
Endocrinology; 1999 Nov; 140(11):5102-11. PubMed ID: 10537138
[TBL] [Abstract][Full Text] [Related]
38. Effect of N-glycosylation on ligand binding affinity of rat V1a vasopressin receptor.
Lee KH; Ahn JI; Yu DH; Jeong HS; Lee SH; Kim KS; Chung IY; Kim JH; Lee YS
Biochem Biophys Res Commun; 2001 Aug; 286(4):707-13. PubMed ID: 11520055
[TBL] [Abstract][Full Text] [Related]
39. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.
Pozvek G; Hilton JM; Quiza M; Houssami S; Sexton PM
Mol Pharmacol; 1997 Apr; 51(4):658-65. PubMed ID: 9106632
[TBL] [Abstract][Full Text] [Related]
40. Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesis.
Popov M; Li J; Reithmeier RA
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):269-79. PubMed ID: 10191257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
